Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis

被引:25
作者
Wijarnpreecha, Karn [1 ]
Werlang, Monia E. [1 ]
Watthanasuntorn, Kanramon [2 ]
Panjawatanan, Panadeekarn [2 ]
Cheungpasitporn, Wisit [3 ]
Gomez, Victoria [1 ]
Lukens, Frank J. [1 ]
Ungprasert, Patompong [4 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 4500 San Pablo Rd S, Jacksonville, FL 32224 USA
[2] Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA
[3] Univ Mississippi, Med Ctr, Dept Med, Div Nephrol, Jackson, MS 39216 USA
[4] Mahidol Univ, Siriraj Hosp, Fac Med, Clin Epidemiol Unit,Dept Res & Dev, Bangkok, Thailand
关键词
Obesity; Overweight; Bacterial overgrowth; Meta-analysis; SMALL-BOWEL MOTILITY; BODY-MASS INDEX; LIVER-CIRRHOSIS; PREVALENCE; INFLAMMATION; RIFAXIMIN; HEALTH;
D O I
10.1007/s10620-019-05887-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Objectives Recent studies have proposed that obesity may be associated with a higher risk of small intestine bacterial overgrowth (SIBO) although the results were inconsistent. The microbiome has a known metabolic role; its impact on obesity in animal models generated the hypothesis of an association between a dysfunctional microbiome and obesity. We performed this systematic review and meta-analysis to elucidate this possible association by summarizing all available data. Methods A literature search utilizing MEDLINE and EMBASE databases from inception until August 2019 was conducted. Eligible studies included either cohort studies or cross-sectional studies that consisted of two groups of participants, those with obesity and those without obesity, and compared the prevalence of SIBO between the groups. Adjusted odds ratios (OR) from each study were consolidated by the generic inverse variance method of DerSimonian and Laird. Results A total of five studies with 515 patients fulfilled eligibility criteria and were included in this meta-analysis. The risk of SIBO among individuals with obesity was higher than in individuals without obesity but did not reach statistical significance with a pooled OR of 2.08 [95% confidence interval (CI) 0.82-5.31; p = 0.12; I-2 84%]. Sensitivity analysis including only studies from Western countries increased the pooled OR to 3.41 and reached statistical significance (95% CI 1.21-9.59; p = 0.02; I-2 62%). Conclusions This meta-analysis found that the risk of SIBO was about two times higher among individuals with obesity compared to individuals without obesity, although the result did not reach statistical significance. The risk increased to threefold and reached statistical significance when only studies from Western countries were included. These observations may suggest the role of obesity as a predisposing factor for SIBO although more studies are still needed to corroborate these preliminary results.
引用
收藏
页码:1414 / 1422
页数:9
相关论文
共 44 条
[1]   Effect of high fat-diet and obesity on gastrointestinal motility [J].
Al Mushref, Mazen ;
Srinivasan, Shanthi .
ANNALS OF TRANSLATIONAL MEDICINE, 2013, 1 (02)
[2]   Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population [J].
Andoh, Akira ;
Nishida, Atsushi ;
Takahashi, Kenichiro ;
Inatomi, Osamu ;
Imaeda, Hirotsugu ;
Bamba, Shigeki ;
Kito, Katsuyuki ;
Sugimoto, Mitsushige ;
Kobayashi, Toshio .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2016, 59 (01) :65-70
[3]   Differences in gut microbiota composition between obese and lean children: a cross-sectional study [J].
Bervoets, Liene ;
Van Hoorenbeeck, Kim ;
Kortleven, Ineke ;
Van Noten, Caroline ;
Hens, Niel ;
Vael, Carl ;
Goossens, Herman ;
Desager, Kristine N. ;
Vankerckhoven, Vanessa .
GUT PATHOGENS, 2013, 5
[4]   Small intestinal bacterial overgrowth syndrome [J].
Bures, Jan ;
Cyrany, Jiri ;
Kohoutova, Darina ;
Foerstl, Miroslav ;
Rejchrt, Stanislav ;
Kvetina, Jaroslav ;
Vorisek, Viktor ;
Kopacova, Marcela .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (24) :2978-2990
[5]  
CHESTA J, 1993, HEPATOLOGY, V17, P828, DOI 10.1016/0270-9139(93)90159-K
[6]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[7]  
Dukowicz Andrew C, 2007, Gastroenterol Hepatol (N Y), V3, P112
[8]   Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease [J].
Fialho, Andrea ;
Fialho, Andre ;
Thota, Prashanthi ;
McCullough, Arthur J. ;
Shen, Bo .
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (02) :159-165
[9]   Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth [J].
Gatta, L. ;
Scarpignato, C. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) :604-616
[10]  
*GLOB HLTH OBS, 2017, NONC DIS OV AD